AngioDynamics anticipates $336M-$341M FY 2027 net sales while targeting $13M-$16M adjusted EBITDA

Q4 FY 2026. Management view "We capped off a year of consistent execution across the business with a strong fourth quarter. Full-year ...
Yahoo Finance

AngioDynamics, Inc. (ANGO) Q1 FY2026 earnings call transcript

Earnings call AngioDynamics delivered Q1 FY26 revenue of $75.7M (+12.2% YoY), driven by 26.1% med-tech growth and strong performance in mechanical thrombectomy (+41.2%) and NanoKnife (+26.7%).
TCTMD

TCT 928: Suction Before Closure: Novel Use of AngioVac Thrombectomy of a Left Atrial Appendage Thrombus to Facilitate Watchman Implantation

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
TCTMD

TCT 173: Complications and Failure Modes of The Angiovac Thrombectomy System: Insight from MAUDE Database

TCT 176: Randomized comparison of intracoronary lithotripsy and rotational atherectomy for the treatment of severely calcified vessels – ROTA.shock trial Receive the the latest news, research, and ...
Yahoo Finance

AngioDynamics Inc (ANGO) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...